From November 1, 2022 to November 2, 2022, the company has repurchased 1,150,602 shares, representing 1.49% for ¥9,991.92 million. With this, the company has completed the repurchase of 1,150,602 shares, representing 1.49% for ¥9,991.92 million under the buyback announced on November 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,564 JPY | -3.00% | +3.00% | -18.06% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.06% | 2.74B | |
+14.40% | 396B | |
+13.58% | 142B | |
+18.09% | 77.56B | |
-12.91% | 65.94B | |
-4.92% | 43.2B | |
+6.63% | 35.03B | |
+11.64% | 18.17B | |
+14.49% | 15.96B | |
-3.84% | 11.51B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.